- NuPathe (NASDAQ:PATH): Wedbush initiated coverage on this stock with a rating of Outperform and a price target of $20. About the company: NuPathe Inc. develops pharmaceutical products used for the treatment and management of neurological and psychiatric diseases. The Company offers various medicines for migraines, Parkinson’s, schizophrenia, and other cognitive disorders.
- Inhibitex (NASDAQ:INHX): Wedbush initiated coverage on this stock with a rating of Outperform and a price target of $9. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting.
- PETsMART (NASDAQ:PETM): RBC Capital Mkts initiated coverage on this stock with a rating of Outperform and a price target of $52. About the company: PetSmart, Inc. is a specialty retailer of products and services for pets. The Company operates pet superstores in the United States and Canada, as well as a pet supply catalog business, and an equity interest in PetSmart.com. PetSmart provides pet food and supplies, and offers full-service veterinary, grooming and pet training services.
- Tronox (TROX): Ticonderoga initiated coverage on this stock with a rating of Buy and a price target of $220. About the company: Tronox Incorporated produces and markets titanium dioxide. The Company’s pigment products are components of everyday consumer applications, such as coatings, plastics, and paper. Tronox also produces electrolytic manganese dioxide, sodium chlorate, and boron-based and other specialty chemicals.
Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>